Effectiveness of duloxetine and venlafaxine in producing increases in extracellular levels of serotonin and norepinephrine in brain

被引:0
|
作者
Wong, DT [1 ]
Bymaster, FP [1 ]
Dreshfield-Ahmad, L [1 ]
机构
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:105 / 106
页数:2
相关论文
共 50 条
  • [11] Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes and other neuronal receptors
    Luecke, SK
    Wong, DT
    Ahmad, LJ
    Threlkeld, PG
    Shaw, JL
    Thompson, LK
    Iyengar, S
    Nelson, DL
    Bymaster, FP
    BIOLOGICAL PSYCHIATRY, 2001, 49 (08) : 162S - 162S
  • [12] EFFECT OF IPRONIAZID ON BRAIN LEVELS OF NOREPINEPHRINE AND SEROTONIN
    SPECTOR, S
    PROCKOP, D
    SHORE, PA
    BRODIE, BB
    SCIENCE, 1958, 127 (3300) : 704 - 704
  • [13] Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex
    Frank P. Bymaster
    Wei Zhang
    Petra A. Carter
    Janice Shaw
    Eyassu Chernet
    Lee Phebus
    David T. Wong
    Kenneth W. Perry
    Psychopharmacology, 2002, 160 : 353 - 361
  • [14] Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex
    Bymaster, FP
    Zhang, W
    Carter, PA
    Shaw, J
    Chernet, E
    Phebus, L
    Wong, DT
    Perry, KW
    PSYCHOPHARMACOLOGY, 2002, 160 (04) : 353 - 361
  • [15] DULOXETINE ELEVATES EXTRACELLULAR SEROTONIN (5-HT) AND NOREPINEPHRINE (NE) IN HYPOTHALAMUS IN-VIVO
    WONG, DT
    PERRY, KW
    ENGLEMAN, EA
    FASEB JOURNAL, 1994, 8 (04): : A107 - A107
  • [16] Duloxetine Increases Serotonin and Norepinephrine Availability in Healthy Subjects: A Double-Blind, Controlled Study
    Stephan A Chalon
    Luc-André Granier
    François R Vandenhende
    Peter R Bieck
    Frank P Bymaster
    Melissa J Joliat
    Christine Hirth
    William Z Potter
    Neuropsychopharmacology, 2003, 28 : 1685 - 1693
  • [17] Duloxetine increases serotonin and norepinephrine availability in healthy subjects: A double-blind, controlled study
    Chalon, SA
    Granier, LA
    Vandenhende, FR
    Bieck, PR
    Bymaster, FP
    Joliat, MJ
    Hirth, C
    Potter, WZ
    NEUROPSYCHOPHARMACOLOGY, 2003, 28 (09) : 1685 - 1693
  • [18] Differential inhibition of cardiac and neuronal Na+ channels by the selective serotonin-norepinephrine reuptake inhibitors duloxetine and venlafaxine
    Stoetzer, Carsten
    Papenberg, Bastian
    Doll, Thorben
    Voelker, Marc
    Heineke, Joerg
    Stoetzer, Marcus
    Wegner, Florian
    Leffler, Andreas
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2016, 783 : 1 - 10
  • [19] Blockade of the serotonin and norepinephrine uptake processes by duloxetine: In vitro and in vivo studies in the rat brain
    Kasamo, K
    Blier, P
    deMontigny, C
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1996, 277 (01): : 278 - 286
  • [20] Effect of chronic administration of duloxetine on serotonin and norepinephrine transporter binding sites in rat brain
    Gould, Georgianna G.
    Javors, Martin A.
    Frazer, Alan
    BIOLOGICAL PSYCHIATRY, 2007, 61 (02) : 210 - 215